56 related articles for article (PubMed ID: 21840775)
1. CK2 phosphorylation of XRCC1 facilitates dissociation from DNA and single-strand break formation during base excision repair.
Ström CE; Mortusewicz O; Finch D; Parsons JL; Lagerqvist A; Johansson F; Schultz N; Erixon K; Dianov GL; Helleday T
DNA Repair (Amst); 2011 Sep; 10(9):961-9. PubMed ID: 21840775
[TBL] [Abstract][Full Text] [Related]
2. XRCC1-mediated repair of strand breaks independent of PNKP binding.
Horton JK; Stefanick DF; Zhao ML; Janoshazi AK; Gassman NR; Seddon HJ; Wilson SH
DNA Repair (Amst); 2017 Dec; 60():52-63. PubMed ID: 29100039
[TBL] [Abstract][Full Text] [Related]
3. Impact of polβ/XRCC1 Interaction Variants on the Efficiency of Nick Sealing by DNA Ligase IIIα in the Base Excision Repair Pathway.
Almohdar D; Gulkis M; Ortiz A; Tang Q; Sobol RW; Çağlayan M
J Mol Biol; 2024 Feb; 436(4):168410. PubMed ID: 38135179
[TBL] [Abstract][Full Text] [Related]
4. The structural basis of XRCC1-mediated DNA repair.
London RE
DNA Repair (Amst); 2015 Jun; 30():90-103. PubMed ID: 25795425
[TBL] [Abstract][Full Text] [Related]
5. DNA single-strand break-induced DNA damage response causes heart failure.
Higo T; Naito AT; Sumida T; Shibamoto M; Okada K; Nomura S; Nakagawa A; Yamaguchi T; Sakai T; Hashimoto A; Kuramoto Y; Ito M; Hikoso S; Akazawa H; Lee JK; Shiojima I; McKinnon PJ; Sakata Y; Komuro I
Nat Commun; 2017 Apr; 8():15104. PubMed ID: 28436431
[TBL] [Abstract][Full Text] [Related]
6. Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Chen X; Legrand AJ; Cunniffe S; Hume S; Poletto M; Vaz B; Ramadan K; Yao D; Dianov GL
Cell Oncol (Dordr); 2018 Oct; 41(5):527-539. PubMed ID: 30088263
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of DNA polymerase beta-dependent base excision repair and increased DMS-induced mutagenicity in aged mice.
Cabelof DC; Raffoul JJ; Yanamadala S; Ganir C; Guo Z; Heydari AR
Mutat Res; 2002 Mar; 500(1-2):135-45. PubMed ID: 11890943
[TBL] [Abstract][Full Text] [Related]
8. Common occurrence of hotspots of single strand DNA breaks at transcriptional start sites.
Cao H; Zhang Y; Song T; Xia L; Cai Y; Kapranov P
BMC Genomics; 2024 Apr; 25(1):368. PubMed ID: 38622509
[TBL] [Abstract][Full Text] [Related]
9. CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy.
Siddiqui-Jain A; Bliesath J; Macalino D; Omori M; Huser N; Streiner N; Ho CB; Anderes K; Proffitt C; O'Brien SE; Lim JK; Von Hoff DD; Ryckman DM; Rice WG; Drygin D
Mol Cancer Ther; 2012 Apr; 11(4):994-1005. PubMed ID: 22267551
[TBL] [Abstract][Full Text] [Related]
10. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
11. Targeting CK2-mediated phosphorylation of p53R2 sensitizes BRCA-proficient cancer cells to PARP inhibitors.
Wang C; Tian L; He Q; Lin S; Wu Y; Qiao Y; Zhu B; Li D; Chen G
Oncogene; 2023 Sep; 42(40):2971-2984. PubMed ID: 37620447
[TBL] [Abstract][Full Text] [Related]
12. Lamin A/C impairments cause mitochondrial dysfunction by attenuating PGC1α and the NAMPT-NAD+ pathway.
Maynard S; Hall A; Galanos P; Rizza S; Yamamoto T; Gram HH; Munk SHN; Shoaib M; Sørensen CS; Bohr VA; Lerdrup M; Maya-Mendoza A; Bartek J
Nucleic Acids Res; 2022 Sep; 50(17):9948-9965. PubMed ID: 36099415
[TBL] [Abstract][Full Text] [Related]
13. CK2 and the Hallmarks of Cancer.
Firnau MB; Brieger A
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009534
[TBL] [Abstract][Full Text] [Related]
14. Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2.
Spinello Z; Fregnani A; Quotti Tubi L; Trentin L; Piazza F; Manni S
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918307
[TBL] [Abstract][Full Text] [Related]
15. DNA‑PKcs inhibitor increases the sensitivity of gastric cancer cells to radiotherapy.
Geng W; Tian D; Wang Q; Shan S; Zhou J; Xu W; Shan H
Oncol Rep; 2019 Aug; 42(2):561-570. PubMed ID: 31173270
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of FANCD2 Inhibits the FANCD2/FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage.
Lopez-Martinez D; Kupculak M; Yang D; Yoshikawa Y; Liang CC; Wu R; Gygi SP; Cohn MA
Cell Rep; 2019 Jun; 27(10):2990-3005.e5. PubMed ID: 31167143
[TBL] [Abstract][Full Text] [Related]
17. Efficient Single-Strand Break Repair Requires Binding to Both Poly(ADP-Ribose) and DNA by the Central BRCT Domain of XRCC1.
Polo LM; Xu Y; Hornyak P; Garces F; Zeng Z; Hailstone R; Matthews SJ; Caldecott KW; Oliver AW; Pearl LH
Cell Rep; 2019 Jan; 26(3):573-581.e5. PubMed ID: 30650352
[TBL] [Abstract][Full Text] [Related]
18. PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand breaks.
Kordon MM; Szczurek A; Berniak K; Szelest O; Solarczyk K; Tworzydło M; Wachsmann-Hogiu S; Vaahtokari A; Cremer C; Pederson T; Dobrucki JW
FASEB J; 2019 Feb; 33(2):2301-2313. PubMed ID: 30260704
[TBL] [Abstract][Full Text] [Related]
19. TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.
Lustri AM; Di Matteo S; Fraveto A; Costantini D; Cantafora A; Napoletano C; Bragazzi MC; Giuliante F; De Rose AM; Berloco PB; Grazi GL; Carpino G; Alvaro D
PLoS One; 2017; 12(9):e0183932. PubMed ID: 28873435
[TBL] [Abstract][Full Text] [Related]
20. Strategies for the evaluation of DNA damage and repair mechanisms in cancer.
Figueroa-González G; Pérez-Plasencia C
Oncol Lett; 2017 Jun; 13(6):3982-3988. PubMed ID: 28588692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
